19:21 , Nov 15, 2017 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Fragile X syndrome Mouse studies suggest inhibiting the eIF4E-eIF4G1 interaction could help treat fragile X syndrome. In a mouse model of fragile X syndrome, a tool compound that inhibits the eIF4E-eIF4G1 interaction increased dendritic...
07:00 , Sep 29, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Parkinson's disease (PD) Eukaryotic translation initiation factor 4g 1 (EIF4G1) In vitro and genetic studies identified mutations in the EIF4G1 gene that could help predict...